Date: 18th Oct 2013
Venue: Rhodes Twenty Four, London
Drugs are a small but easily identifiable component in the multi-modal approach to modern treatment. The future is harnessing the power of molecular diagnostics to personalise care and so increase its cost-effectiveness.
Join us for an evening of knowledge sharing where we shall:
- Explore new cancer drugs
- Investigate the latest oncological clinical trials
- Discover why response signatures based on tissue diagnostics are urgently needed
- Focus on why all healthcare systems are struggling with the increasing costs of cancer treatment.
Who should attend:
- Heads of R&D
- Therapeutic Area Heads
- Clinical Trial Managers